AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Mar 18, 2015
30071_dirs_2015-03-18_2947e287-c7de-4717-ab8a-20373ea82b62.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-03-16
Reporting Person: Farrell Michael J. (Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-16 | ResMed Common Stock | M | 300 | $21.675 | Acquired | 122655.941 | Direct |
| 2015-03-16 | ResMed Common Stock | S | 300 | $69.10 | Disposed | 122355.941 | Direct |
| 2015-03-16 | ResMed Common Stock | M | 5675 | $15.52 | Acquired | 128030.941 | Direct |
| 2015-03-16 | ResMed Common Stock | S | 5675 | $69.10 | Disposed | 122355.941 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-16 | ResMed Common Stock Options | $21.675 | M | 300 | Disposed | 2015-10-01 | ResMed Common Stock (300) | Direct |
| 2015-03-16 | ResMed Common Stock Options | $15.52 | M | 5675 | Disposed | 2015-11-20 | ResMed Commmon Stock (5675) | Direct |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/4 annually.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29